Giovanni Caforio, Bristol Myers Squibb CEO (Nicolas Messyasz/Sipa via AP Images)

Gio­van­ni Caforio to step down as Bris­tol My­ers CEO, with Chris Boern­er named suc­ces­sor

Gio­van­ni Caforio will step down as Bris­tol My­ers Squibb’s CEO on Nov. 1, the New York phar­ma gi­ant said Wednes­day, as part of a broad­er lead­er­ship shake­up.

Caforio, 58, has worked at Bris­tol My­ers since 2000 and has served as CEO since May 2015, over­see­ing a pe­ri­od of growth that in­clud­ed the $74 bil­lion ac­qui­si­tion of Cel­gene. When he steps down lat­er this year, Caforio will serve as ex­ec­u­tive chair­man, ac­cord­ing to a news re­lease, and Chris Boern­er will take the reins as the next CEO of the $143 bil­lion com­pa­ny. Boern­er has been BMS’ chief com­mer­cial­iza­tion of­fi­cer, with the phar­ma nam­ing him chief op­er­at­ing of­fi­cer ef­fec­tive im­me­di­ate­ly.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.